Evidence map›Paper›PMID 18940916›Full record

ReviewEndocrine reviews2008

Motivations and methods for analyzing pulsatile hormone secretion.

Johannes D Veldhuis, Daniel M Keenan, Steven M Pincus

Abstract readReview
In one paragraph

Review in Endocrine reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Acute Effects of Glucagon on Reproductive Hormone Secretion in Healthy Men.The Journal of clinical endocrinology and metabolism · 2020
    Trial
  5. Trial
  6. Effects of Increased Frequency, High Dose, and Pulsatile Oxytocin Regimens on Abnormal Labor Delivery.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Differential pulsatile secretagogue control of GH secretion in healthy men.American journal of physiology. Regulatory, integrative and comparative physiology · 2013
    Trial

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Johannes D VeldhuisEndocrine Research Unit, Department of Internal Medicine, Mayo Medical School, Mayo School of Graduate Medical Education, Center for Translational Science Activities, Mayo Clinic, Rochester, Minnesota 55905, USA. Veldhuis.Johannes@mayo.edu
Daniel M Keenan
Steven M Pincus

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Age-Dependent Estrogen-Independent Mechanism of Hyposomatotropism in WomenR01AG029362 · NIA · MAYO CLINIC ROCHESTER · PI VELDHUIS, JOHANNES D · 2007 to 2016
$4.0M
ACTIONS OF TESTOSTERONE ON THE AGING MALE GH AXISR37AG019695 · NIA · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI VELDHUIS, JOHANNES D · 2001 to 2011
$3.2M
Actions of Testosterone on the Aging Male GH AxisR01AG019695 · NIA · MAYO CLINIC ROCHESTER · PI VELDHUIS, JOHANNES D · 2012 to 2016
$1.9M
Ensemble Control of ACTH Secretion: Impact of GenderR01DK073148 · NIDDK · MAYO CLINIC ROCHESTER · PI VELDHUIS, JOHANNES D · 2007 to 2011
$1.4M
Ensemble Disruption of the GnRH-LH-Testosterone AxisR01AG023133 · NIA · MAYO CLINIC ROCHESTER · PI VELDHUIS, JOHANNES D · 2004 to 2007
$1.3M
Analytical Reconstruction of Feedback Signaling in Aging MenR21AG029215 · NIA · MAYO CLINIC ROCHESTER · PI VELDHUIS, JOHANNES D · 2007 to 2008
$330k
Mechanistic bases for age-related androgen deficiencyR21AG023777 · NIA · MAYO CLINIC ROCHESTER · PI VELDHUIS, JOHANNES D · 2006 to 2007
$328k
NCRR NIH HHS M01 RR000585NCRR NIH HHS M01 RR00585NIA NIH HHS AG23133NIA NIH HHS AG23777NIA NIH HHS AG29362NIA NIH HHS R01 AG019695NIA NIH HHS R01 AG023133NIA NIH HHS R01 AG029362NIA NIH HHS R01 NIA AG019695NIA NIH HHS R21 AG023777NIA NIH HHS R21 AG029215NIA NIH HHS R21 AG29215NIA NIH HHS R37 AG019695NIDDK NIH HHS DK73148NIDDK NIH HHS R01 DK073148
6 · The paper itself

Abstract

Endocrine glands communicate with remote target cells via a mixture of continuous and intermittent signal exchange. Continuous signaling allows slowly varying control, whereas intermittency permits large rapid adjustments. The control systems that mediate such homeostatic corrections operate in a species-, gender-, age-, and context-selective fashion. Significant progress has been made in understanding mechanisms of adaptive interglandular signaling in vivo. Principal goals are to understand the physiological origins, significance, and mechanisms of pulsatile hormone secretion. Key analytical issues are: 1) to quantify the number, size, shape, and uniformity of pulses, nonpulsatile (basal) secretion, and elimination kinetics; 2) to evaluate regulation of the axis as a whole; and 3) to reconstruct dose-response interactions without disrupting hormone connections. This review will focus on the motivations driving and the methodologies used for such analyses.

Indexed as

AnimalsEndocrine GlandsHormonesHumansPulsatile FlowSecretory RateHormones

Identifiers

PMID18940916
PMCPMC2647703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.